In a model system to study factors involved in the establishment of a persistent viral infection that may lead to neurodegenerative diseases, Indiana and New Jersey variants of vesicular stomatitis virus (VSV) with different capacities to infect and persist in human neural cells were studied. Indiana matrix (M) protein mutants and the wild-type New Jersey strain persisted in the human neural cell line H4 for at least 120 days. The Indiana wild-type virus (HR) and a non-M mutant (TP6), both unable to persist, induced apoptosis more strongly than all the other variants tested, as indicated by higher levels of DNA fragmentation and caspase-3-like activity. Transfection of H4 cells with mRNA coding for the VSV M protein confirmed the importance of this protein in the induction of apoptosis. Furthermore, the pan-caspase inhibitor ZVAD-fmk maintained cell survival to about 80%, whereas inhibition of caspase-8, caspase-9, or both only partially protected the cells against death, consistent with the fact that anti-apoptotic molecules from the Bcl-2 family also protect cells from death only partially. These results suggest that VSV activates many pathways of cell death and that an inefficient induction of caspase-3-related apoptosis participates in the establishment of a persistent infection of human neural cells by less virulent VSV variants.
INTRODUCTION
Neurodegenerative diseases may be linked to persistent viral infections of the central nervous system (CNS). Indeed, viral induction of long-term neuropathology is well described for subacute sclerosing panencephalitis and measles virus (Haase et al., 1985; SchneiderSchaulies and ter Meulen, 1999 ), Theiler's murine encephalitis virus-induced demyelination disease in mice (Miller et al., 1997; Tsunoda et al., 1997) , and subtle neurological deficit associated with lymphocytic choriomeningitis virus (Oldstone, 1989) . The murine coronavirus mouse hepatitis virus (MHV) also provides a useful model for demyelinating diseases such as multiple sclerosis (Castro et al., 1994; Houtman and Fleming, 1996; Wege et al., 1998; Buchmeier and Lane, 1999) and can persist in neural cells (Lavi et al., 1987; Chen and Baric, 1996) . Furthermore, the human counterparts of MHV, human coronavirus strains HCoV-229E and HCoV-OC43, present a special interest in relation to persistent viral infection of the CNS as viral RNA was detected by RT-PCR in human brain tissue (Arbour et al., 2000) , and both strains can persistently infect human neural cells (Arbour et al., 1999a, b) .
A viral infection is one of several factors that, taken together, can lead to a chronic neuropathology . In several of these pathologies, a persistent infection, whereby a virus has elaborated a strategy of nonlytic replication in the infected cells, often seems to be a key factor in the triggering of illness (de la Torre and Oldstone, 1996) . Among the various viruses that have been studied for viral and cellular functions involved in the initiation of a persistent infection is the vesicular stomatitis virus (VSV), a member of the Rhabdoviridae family from the Mononegavirales order. This virus is usually highly cytopathic, but has also been shown to persist in cell culture Huprikar et al., 1986; Desforges et al., 2001) and to infect the CNS (Huneycutt et al., 1994; Plakhov et al., 1995) where at least viral RNA can persist (Fultz et al., 1982; Barrera and Letchworth, 1996) .
The cytopathic effect (cpe) caused by VSV usually leads rapidly to cell death. One important mechanism that may be involved in virus-mediated cell death is apoptosis, which appears to be induced by various DNA and RNA viruses (see reviews by Razvi and Welch, 1995; Teodoro and Branton, 1997; Griffin and Hardwick, 1999) . It has also been shown that the wild-type Indiana (Bi et al., 1995; Balachandran et al., 2000 Balachandran et al., , 2001 and New Jersey (Koyama, 1995) strains of VSV can induce apoptosis.
Apoptosis is a complex and highly regulated mechanism that usually results in the activation of a special type of cysteine protease called the caspases (cysteinedependent aspartate-specific proteases). By initiating a complex cascade of reactions that usually involve these caspases, the cell finally kills itself (Nunez et al., 1998; Earnshaw et al., 1999; Hengartner, 2000) . In the situation of a viral infection, apoptosis may have various consequences. The first is to limit the inflammatory response (Teodoro and Branton, 1997; Marcellus et al., 1998) , a situation which can be beneficial to the virus for evading the immune system of the host more efficiently. In some cases, apoptosis may even enable virus spread, as has been suggested for HIV (Strack et al., 1996) . Nevertheless, apoptosis may also represent a potent defense mechanism for the host, limiting viral proliferation in the infected organism (Tsunoda et al., 1997; Allsopp et al., 1998) . However, cell death itself may contribute to and enhance pathogenesis (Jelachich and Lipton, 1996; Ubol et al., 1998) . In the end, the modulation of this complex mechanism can sometimes be profitable to the virus and deleterious to the host. If apoptosis is not induced correctly or not induced at all in a context where it should be, it may allow the establishment of a persistent infection by a virus that should have been eliminated otherwise. In the present study we used an in vitro system to investigate factors that could be associated with inefficient regulation of virus-induced apoptosis at the cellular level and thereby with the initiation of a persistent infection in neural cells.
We report that VSV induces apoptosis in human neural cells in culture and that this is at least in part related to the viral matrix (M) protein. Indeed, the Indiana strain of VSV induced apoptosis very rapidly with more than 90% of all cells killed by 48 h postinfection (p.i.). On the other hand, a series of M protein mutants of the Indiana strain (Francoeur et al., 1987; Desforges et al., 2001 ) and the less cytopathic wild-type New Jersey strain induced cell death by apoptosis but to a lesser extent, thereby allowing the establishment of a persistent infection of the neural cells. Thus, VSV may provide a good model to characterize the importance of the regulation of apoptosis as a mechanism involved in the control of viral persistence in cells of the central nervous system.
RESULTS

Human neural cells sustain persistent infection
The human H4 neural cell line sustained a persistent productive infection by the M protein mutants of the Indiana serotype and by the wild-type New Jersey for at least 120 days (Fig. 1A, Table 1) . A representative series of microscopic immunodetections of viral proteins during persistence in neural cells is shown in Fig. 1B . VSV Indiana variants induced a high level of viral antigen production in a small number of cells, whereas VSV New Jersey induced the production of a low level of viral antigen in the majority of cells. Figure 1A shows that the end result in either case was similar levels of production of infectious particles through 120 days. On the other hand, cells infected by Indiana variants without any mutation in the M gene (HR-Ind and TP6) could not sustain long-term infection, even when low multiplicity of infection (m.o.i.) (0.01) was used to start the infection (data not shown). In fact, all cells were killed between 48 and 72 h p.i. when the infection was initiated at an m.o.i. of 1 by these viruses (Fig. 2A) . In comparison, cell cultures remained viable throughout infection by Indiana M protein mutants or wild-type New Jersey ( Fig. 2A ) even though there was no significant difference in production of infectious virus (Fig. 2B ) except for mutant T1026, which has a thermosensitive mutation in the L gene and for TP6 at 72 h p.i.
Short-term events show that infected cells die by several pathways of apoptosis
To identify mechanisms that are important in the establishment of the persistent infection, the induction of Rose and Galione (1981) . b Sequence of M gene; Desforges et al. (2001) . c The M gene sequence of the New Jersey Hazelhurst serotype is not known but the sequence of the Ogden serotype presents a 62% homology with Indiana; Gill and Banerjee (1986) . cell death in short-term infections of human neural cells was analyzed. All viruses studied induced apoptosis of neural cells as seen by TdT-dUTP nick end labeling (TUNEL)-positive reaction at 16 h p.i. (Fig. 3A) and DNA fragmentation (Fig. 3B) . It is notable that the percentage of TUNEL-positive cells was higher and the characteristic DNA laddering was stronger and observed earlier in cells infected with HR-Indiana and TP6 than in cells infected with M mutant T1026R1 and New Jersey wildtype viruses. Caspase activity in extracts from virusinfected H4 cells was measured using a chromogenic substrate for caspase-3 as an additional test for the induction of apoptosis. This enzymatic activity was clearly induced to a lesser extent by infection with the Indiana M protein mutants and wild-type New Jersey serotype viruses compared to HR and TP6 viruses (Fig.  4A ). These results were confirmed by analysis of cleavage of procaspase-3 by Western blots (Fig. 4B) . More of the activated 17-to 19-kDa caspase-3 fragments were generated in H4 cells infected with HR-Indiana and TP6 viruses than in cells infected with M mutant T1026R1 and New Jersey wild-type viruses. Thus, although hallmarks of apoptosis could be observed for all VSV variants, they appeared weaker in Indiana M mutants and wild-type New Jersey infections, correlating with the differences in cell viability ( Fig. 2A) .
To further determine the apoptotic pathways induced by the different VSV variants, neural cells were infected in the presence of various apoptosis inhibitors. Infection in the presence of a pan-caspase inhibitor of apoptosis, ZVAD-fmk, protected H4 neural cells. Indeed, even at 2 days p.i., cells retained up to 80% of their mitochondrial metabolic activity depending on the virus (Fig. 5A ). On the other hand, cells infected in the presence of 70 M concentrations of inhibitors of caspase-8 (Z-IETD-fmk) or caspase-9 (Z-LEHD-fmk) did not sustain infection as well, as neither inhibitor was able to protect the cells from death as efficiently as ZVAD-fmk for more virulent nonpersisting viruses. ZFA-fmk is the negative control for ZVAD-fmk, as it does not inhibit any known caspases. It protected the cells to a much lesser extent (Fig. 5A) . Moreover, stable overexpression of anti-apoptotic molecule Bcl-2 and to a lesser extent Bcl-XL was correlated with an increased survival of infected cells (Figs. 5B and 5C) and did permit the establishment of a long-term infection for at least 2 weeks by VSV-HR-Indiana when infection was initiated at an m.o.i. of 0.01 or less (data not shown). On the other hand, neither of these anti-apoptotic molecules led to VSV-TP6 persistence in H4 cells (data not shown).
Inhibition of caspase-related apoptosis allows a more effective production of virus As ZVAD-fmk protected cells from VSV-induced caspase-associated apoptosis, we wished to determine whether this protection had any effect on viral replication. Measurement of infectious virus titers (plaque-forming units, PFU) indicated that inhibition of caspases allowed production of infectious virus for a longer period of time (Fig. 6A ). As shown in Fig. 6B , inhibition of caspases using ZVAD-fmk led to an increased production of infectious virus by up to Ϫ2 logs for all Indiana variants. Thus, inhibition of apoptosis appears to participate in a better propagation of infectious VSV between 45 and 72 h p.i., with the exception of wild-type New Jersey (Fig. 6B) .
M protein participates in DNA fragmentation
Recent results (Despars et al., unpublished results; Kopecky et al., 2001) point to the involvement of the M protein in the apoptosis induction process. Thus, we tested whether production of M protein in the absence of other viral components was sufficient to induce apoptosis in H4 cells. In view of the inhibitory effect of M protein on host transcription, M protein was expressed from transfected mRNA rather than plasmid DNA, since M protein inhibits its own expression from DNA vectors that depend on host transcriptional activity (Black and Lyles, 1992; Black et al., 1994) . Expression of either wild-type or T1026R1 mutant M protein alone in H4 neural cells induced DNA fragmentation at 18 h posttransfection as shown in Fig. 7 , which is representative of two different experiments. In both experiments, it appeared that wildtype M protein led to a stronger positive TUNEL reaction than the T1026R1 mutant and vehicle (lipofectamine alone), in agreement with DNA fragmentation observed during whole virus infection (Figs. 3A and 3B).
DISCUSSION
Given the observation that several viruses induce or modulate apoptosis, it appears that this process is a key factor in the complex regulation that takes place to control the infection, including modulation from an acute infection to viral persistence. The central nervous system represents a privileged site for viral persistence and this could indicate relevance to the development of neurological disorders. Therefore, we wished to study how a viral infection can become persistent in a neural cell model. For that purpose, we used VSV, a usually highly cytopathic virus that has been shown to induce apoptosis (Bi et al., 1995; Balachandran et al., 2000 Balachandran et al., , 2001 Koyama, 1995) as well as to persist in the nervous system (Fultz et al., 1982; Barrera and Letchworth, 1996) and for which we possess a series of attenuated mutants.
Induction of DNA fragmentation and activation of caspase-3-like proteases are usually important hallmarks of apoptosis, and their extent is correlated with the degree of apoptosis. The fact that a reduced activation of these markers occurs in cells infected by Indiana M protein mutants and wild-type New Jersey compared to Indiana wild type (Figs. 3 and 4) is crucial as it correlated with a limited induction of cell death, thereby allowing survival of a large portion of the infected cells ( Fig. 2A) and providing the virus a reservoir to maintain itself (Fig. 1) . Expression of the M protein alone in H4 cells induced apoptosis, as seen by DNA fragmentation (Fig. 7) . The apparent difference in the degree of apoptosis induced by wild type and the T1026R1 mutant M protein is very interesting as it correlates with results observed during viral infection (Figs. 3A and 3B ) and with the fact that the only difference between the wild-type virus HR-Ind and the mutant T1026R1 genomes is in the M gene, as we have previously shown (Desforges et al., 2001 ; see Table 1 ). Furthermore, this difference in induction of apoptosis between wild-type and mutant M protein is supported by recent results which indicate that expression of a similar mutant M protein expressed alone in HeLa or BHK cells activates little if any caspase-3 (Kopecky et al., 2001) .
Overexpression of Bcl-2 has already been shown to be associated with persistent infection of cells by other cytopathic viruses such as Sindbis virus (Levine et al., 1993) , Semliki Forest virus (Scallan et al., 1997) , and Japanese encephalitis virus (Liao et al., 1998) . In our system, cells overexpressing Bcl-XL and especially Bcl-2 survived significantly better to infection (Figs. 5B and 5C) especially when infection was done at a low m.o.i. This ectopic expression of anti-apoptotic molecules even allowed HR-Indiana virus to persist in culture when the infection was initiated at 0.01 PFU/cell (data not shown), indicating that those anti-apoptotic Bcl-2 family members are of some importance for the control of VSV-induced apoptosis and possible viral persistence. Further analyses of the possible modulation of regulatory proteins such as anti-apoptotic Bcl-2 and Bcl-XL and of proapoptotic Bax and Bid are currently being performed to further characterize the mechanisms underlying VSVinduced apoptosis.
Our results so far indicate that there may be other pathways involved in VSV-induced apoptosis besides the mitochondrial pathway which is regulated by the Bcl-2 family of proteins. Indeed, inhibition of caspase-9 protected cells from death only partially and for both Indiana variants with wild-type M protein (HR and TP6), to the same level as inhibition of caspase-8 (Fig. 5A) , which can be independent of mitochondria-related apoptosis by directly activating the effector caspase-3 (Hentgartner, 2000) . Partial protection by caspase-8 and -9 inhibitors therefore suggests that intrinsic (caspase-9 associated) and extrinsic (caspase-8 associated) pathways of apoptosis are both important in regulating VSV-induced apoptosis, as is the case for Sindbis virus (Nava et al., 1998) . Moreover, the pan-caspase inhibitor ZVAD-fmk provided protection from VSV-induced cell death, as up to 80% of mitochondrial metabolic activity remained at 48 h p.i. (Fig. 5A ) and up to 70% at 68 h p.i. (data not shown). This indicates that caspase-related apoptosis is implicated in cell death but also that a fraction of the cells may die by alternative pathways such as passive necrosis. Poliovirus has been shown to induce cell death by distinct pathways which could lead to caspase-related apoptosis or classical cpe leading to death even in the presence of caspase inhibitors (Agol et al., 1998) . Moreover, ZVAD-fmk did not completely provide protection from cell rounding, a well-documented VSV-induced cpe. Others have recently observed the same pattern of survival during VSV infection of C6 rat glial cells when using ZVAD-fmk and specific inhibitors of caspase-8, -9, or even -3 (Balachandran et al., 2001) . Even though the mean metabolic activity of H4 cells infected by M mutant T1026R1 appeared to be reduced in the presence of caspase-9 inhibitor (Z-LEHD) compared to ZVAD, the difference is not significantly different (ANOVA, P Ͼ 0.05). This could indicate differences in the induction of apo- ptotic pathways between M mutants and wild-type Indiana. On the other hand, like cells infected with wild-type Indiana virus, infection with this mutant in the presence of both Z-LEHD and Z-IETD did not protect the cells from death as well as ZVAD (ANOVA, P Ͻ 0.01), suggesting that other proteases are involved in the induction of apoptosis. Calpain is a cysteine protease that has been linked to activation of caspase-3 in rat brain (Blomgren et al., 2001) , and it can be activated during reovirus infection (Debiasi et al., 1999) . Given these facts, characterization of calpain activation during infection by our different VSV variants is currently under way to determine whether it could account for differences in caspase-3 activation by the less cytopathic viruses.
It has been reported that VSV was partially inhibited in its capacity to produce infectious virions in Hep-2 cells undergoing apoptosis (Koyama et al., 1998) . Despite a 10-fold reduction in virion production at 10 h p.i. when cells were undergoing apoptosis, these authors suggested that the replicative cycle of VSV was not significantly affected. Although our results indicate the same tendency, the differences appeared at later times, ZVADfmk being associated with a better production of infectious virions for Indiana variants between 45 and 72 h p.i. (Figs. 6A and 6B ). At this time in the infection, the increase in titer of infectious virions reached its maximum and went as high as 283-fold for TP6 when caspases are inhibited by ZVAD-fmk. This is in agreement with the fact that during a normal infection, there is an important drop of plaque-forming unit production for TP6 between 45 and 72 h (Fig. 2B) .
In conclusion, it appears from our results that apoptotic cell death is important during VSV infection and that a restricted activation of this pathway by less cytopathic variants of VSV may lead to a persistent infection of neural cells. Moreover, VSV-induced apoptosis during wild-type Indiana infection seems to be a potent mechanism to limit viral replication and to prevent viral persistence in a human neural cell line. Infection of neural cells in vitro does not necessarily re-create all the complexity of the CNS but viral persistence at this privileged site has been extensively described. Of course, further investigation must be made to correlate our results to the situation in vivo. However, it is already known that VSV mutant T1026 is associated with possible persistence and delayed CNS pathology in newborn hamsters . Moreover, modulation of apoptosis has been described as a viral strategy that can permit the establishment of persistence in other systems (Shen and Shenk, 1995; Hardwick, 1998; Kalvakolanu, 1999) . Hallmarks of apoptosis have been reported to appear in the mouse olfactory bulb during VSV Indiana wild-type infection. Thus, studying how the apoptotic process may be modulated or impaired during infection of neural cells should further our understanding of the establishment of a long-term infection that may be associated with neurodegenerative diseases. Further investigation also remains necessary to explain the complete pathways of programmed cell death related to VSV infection of neural cells. In trying to identify what cellular and viral factors are important for cell death to happen it should be possible to understand why and how persistent infection can be established and maintained in neural cells by usually cytopathic viruses such as VSV. Furthermore, knowing that VSV is currently studied in relation to its possible use in cancer therapy (Stojdl et al., 2000; Balachandran et al., 2001) , it is of major importance to understand how VSV persistence may appear in infected cells, especially in the CNS.
MATERIALS AND METHODS
Cell lines and viruses
The simian kidney fibroblast Vero cells (ATCC-CCL-81) used for virus titration experiments were grown to 100% confluence before infection at 37°C in a 5% (v/v) CO 2 atmosphere, in MEM ␣ medium supplemented with 10% (v/v) calf serum, penicillin G (100 units/ml), streptomycin sulfate (100 g/ml), and fungizone (2.5 g/ml amphotericin B and 2.5 g/ml sodium deoxycholate). The human neural cell line H4 (ATCC-HTB-148) was grown the same way except that DMEM supplemented with 10% (v/v) fetal calf serum (FCS) was used. The wild-type HR strain of VSV Indiana has been described elsewhere, as were the M mutants derived from it (Francoeur et al., 1987; Desforges et al., 2001) . The New Jersey Hazelhurst strain was a gift from Dr. Yong Kang (University of Western Ontario). Experimental infections were performed at m.o.i. values ranging from 0.01 to 1. For the infection of the H4 cells, all viruses were diluted in PBS containing 2% (v/v) FCS and incubated with the cells in a minimal volume for 1 h at 37°C to allow adsorption and penetration into the cells, before being washed once with PBS and addition of complete DMEM (all cell culture products were from Canadian Life Technologies).
Indirect immunofluorescence
H4 cells (1.5 ϫ 10 4 ) persistently infected were seeded on 12-well multitest slides (ICN Biomedicals) and fixed the next day with cold acetone. Detection of viral antigen was performed the next day using a rabbit polyclonal antibody against VSV antigen (1/500) as primary antibody, and secondary antibody was F(abЈ) 2 anti-rabbit coupled to FITC (1/100). After detection of viral antigen with specific antibody, cells were counterstained with Evans blue dye to allow the visualization of all the cells in the culture.
Cell viability
Viability of the cells was estimated by Trypan blue dye exclusion. Briefly, after a 2-min treatment with 0.25% trypsin (w/v), cells were resuspended in 2 ml of complete DMEM. An aliquot was then mixed with 1 vol of 0.4% (w/v) Trypan blue and the viability of the cells was estimated by microscopic observation on an hemacytometer.
Metabolic activity of the cells in the presence of apoptosis inhibitors
The MTS/PMS tetrazolium assay (Cory et al., 1991) was used to measure the survival of the culture after infection. MTS (Promega) was added to the culture medium (final concentration of 0.6 mM) with PMS (SigmaAldrich) (final concentration of 0.014 mM). The reduction of MTS, a measure of mitochondrial respiration and therefore a direct indication of cell viability and viral cytotoxicity, is monitored by optical density reading at 540 nm. The cells were preincubated for 2 h with complete DMEM high glucose alone or with medium containing 0.2% (v/v) DMSO, 100 M ZFA-fmk, or 100 M ZVAD-fmk (Enzyme System Products). The infection was performed as described earlier at an m.o.i. of 1 for 1 h and then complete DMEM was added, either alone or with 0.2% (v/v) DMSO, 100 M ZFA-fmk (inhibitor of cysteine proteases other than caspases), or 100 M ZVADfmk (pan-caspase inhibitor), 70 M Z-IETD-fmk (inhibitor of caspase-8), or 70 M Z-LEHD-fmk (inhibitor of caspase-9) (Enzyme System Products).
Establishment of cell lines and clones overexpressing
Bcl-2 and Bcl-XL Transfection of 1 g of DNA from pRSV-HA-Bcl-2-neo or pcDNA-HA-Bcl-XL-neo (a kind gift from Dr. Gordon Shore, McGill University) or pRSV-neo as control (a gift from Dr. É ric Rassart, University of Quebec at Montreal) was performed using 10 l of lipofectamine (InvitrogenLife Technologies) on 2 ϫ 10 5 H4 cells at 2/3 confluence in 6-well plates (Falcon Catalog No. 3046) . Selection of H4 cell subpopulations and isolated clones overexpressing either Bcl-2 or Bcl-XL was performed with G418 (Invitrogen-Life Technologies) at 1 mg/ml and then kept under selection at 500 g/ml of this selecting agent. The viability of subpopulations composed of 50 different clones overexpressing Bcl-2 was evaluated by Trypan blue dye exclusion, and the metabolic activity of isolated clones overexpressing either Bcl-2 or Bcl-XL was evaluated by the MTS/PMS tetrazolium assay.
Infectious viral particle production
Aliquots of medium were taken at different times during the course of the infection and titrated to evaluate whether or not the infection was productive. The plaque assay was performed by infecting confluent Vero cells grown in 6-well plates (Falcon Catalog No. 3046) using serial dilutions in PBS supplemented with 2% (v/v) FCS. After a 1-h incubation in a minimal volume, complete MEM ␣ medium containing 0.2% (w/v) agarose was added (Desforges et al., 2001) . Infectious virus titers were expressed as plaque-forming units per milliliter.
DNA fragmentation and TUNEL
After infection, DNA was extracted from 4 ϫ 10 6 cells as described elsewhere (Appel et al., 2000) . Briefly, detached and adherent cells were collected, washed with cold PBS, and lysed on ice for 1 h in 1 ml of cold lysis buffer (10 mM Tris, pH 7.5, 10 mM EDTA, and 0.2% (v/v) Triton X-100). Lysates were centrifuged at 10,000 g for 20 min at 4°C, and low-molecular-weight DNA was extracted by conventional phenol, phenol-chloroform, and chloroform extractions and precipitated with ethanol. The pellet was resuspended in 25 l of water and treated for 30 min with RNase A (10 g/l) at 37°C. Samples were then run on a 1.8% (w/v) agarose gel in Tris-borate-EDTA buffer stained with ethidium bromide (0.5 g/ml).
For TUNEL staining, 1.5 ϫ 10 4 cells were infected on 16-well glass slides (Nunc), fixed with freshly prepared 4% (v/v) paraformaldehyde in PBS at room temperature, and permeabilized with 0.2% (v/v) Triton X-100-0.2% (w/v) sodium citrate for 3 min on ice. Labeling was performed according to the manufacturer's instructions (Roche Diagnostics) except that the labeling solution was previously diluted by 50% with a solution containing 30 mM Tris, pH 7.2, 140 mM sodium cacodylate, and 1 mM CoCl 2 .
Measurement of caspase-3-like activity
Induction of caspase-3-like activity in cells was measured with a caspase-3 colorimetric assay (R&D Systems) as described by the manufacturer. Briefly, 4 ϫ 10 6 cells were infected at an m.o.i. of 1, and floating and adherent cells were recovered together at the indicated times postinfection. After two washes in cold PBS, cells were counted, lysed in buffer (25 l per 1 ϫ 10 6 cells), and left on ice for 10 min. Lysates were cleared by a 1-min centrifugation at 10,000 g and kept at Ϫ80°C until analysis. Caspase-3-like activity was measured by optical density reading at 405 nm after a 2-h incubation period at 37°C.
Fifty micrograms of total cell extract proteins was migrated on a 12.5% acrylamide gel and transferred to a PVDF membrane (Millipore) using a semidry apparatus (Bio-Rad). Western blotting was performed using anticaspase-3 rabbit antiserum (a kind gift from Dr. Michele Barry, University of Alberta), diluted 1/5000 in TBS-0.1% Tween-20 containing 5% nonfat dry milk. Secondary antibody was anti-rabbit HRP (Amersham Biosciences) diluted 1/5000 in TBS-0.1% Tween-20. Visualization was performed using an ECL detection kit (Amersham Biosciences).
Cloning and transfection of viral M gene in neural cells
The M gene cDNAs (wild-type MTP6 and N-terminal mutant MT1026R1) were prepared as described elsewhere (Desforges et al., 2001 ) and cloned in pSD4, a plasmid derived from vector pSP65 (Invitrogen-Life Technologies), which contains the Sp6 phage promoter for in vitro transcription. The mRNAs were synthesized in vitro using mMessage mMachine Sp6 kit (Ambion). The quantity and quality of mRNAs were double-checked by optical density reading at 260 nm and by electrophoresis on agarose gel.
The day before transfection, H4 cells were seeded at 3 ϫ 10 4 cells/well in 4-well slides (Nunc). Cells were transfected with 0.15 g of mRNA transcribed in vitro and 2.5 l of lipofectamine according to the manufacturer's instructions (Invitrogen-Life Technologies). Cells were then fixed with 4% (w/v) paraformaldehyde 18 h posttransfection. The TUNEL reaction was performed as indicated for VSV infections.
